Spineart has strengthened its production capacity with the acquisition of Alpes-CN, a recognized expert in spinal implant manufacturing. This key step in Spineart’s expansion will support the Company’s rapid growth while maintaining the highest level of customer service.
Since the first half of 2016, Spineart has maintained a steady growth rate of 25.6% worldwide. Driving these results is a 35.7% increase in US sales, a 25.1% increase in direct country sales, as well as several new product launches, including the Company’s proprietary Ti-Life Technology, a 3D-printed macroporous scaffold that mimics trabecular bone.